The initial experience with the Embotrap III stent-retriever in a real world setting.

IF 1.7 4区医学 Q3 Medicine

Interventional Neuroradiology Pub Date : 2024-10-01 Epub Date: 2022-12-15 DOI:10.1177/15910199221142097

Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal

{"title":"The initial experience with the Embotrap III stent-retriever in a real world setting.","authors":"Osama Omrani, Nema Hafezi-Bakhtiari, Peter DeSouza, Christos Nikola, Ken Wong, Joseph Lansley, Permesh Dhillon, Levansri Makalanda, Nathan Chan, Thomas Harrison, Alex Andrews, Isabel Siow, Keng Siang Lee, Leonard Yeo, Oliver Spooner, Pervinder Bhogal","doi":"10.1177/15910199221142097","DOIUrl":null,"url":null,"abstract":"Materials and methods: We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.Results: One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (n = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (n = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (n = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (n = 64).Conclusion: The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.","PeriodicalId":14380,"journal":{"name":"Interventional Neuroradiology","volume":" ","pages":"663-671"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569467/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Neuroradiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15910199221142097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Materials and methods: We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS.

Results: One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (n = 55). The median NIHSS at presentation was 18 (range 3-30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (n = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (n = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (n = 64).

Conclusion: The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients.

查看原文本刊更多论文

Embotrap III 支架截留器在实际应用中的初步经验。

材料和方法：我们对前瞻性维护的数据库进行了回顾性审查，以确定2021年1月至2022年1月期间使用Embotrap 3支架回流器治疗的所有患者。我们记录了基线人口统计学、NIHSS、ASPECT 评分和血栓特征、首次通过和最终 eTICI 评分、并发症和 90 天 mRS：110名患者符合纳入标准，平均年龄（69 ± 14）岁，50%为男性（n = 55）。发病时的 NIHSS 中位数为 18（3-30），58.2% 的患者在 MT 前接受了静脉 tPA 治疗。CT 平扫的 ASPECT 评分中位数为 8 分，血栓平均长度为 20.2 ± 14.8 mm（n = 93）。41.8%的病例出现首过效应（FPE），59.1%的病例出现改良FPE。24 小时 CT 扫描（n = 97）显示中位 ASPECTs 为 7，43.8% 的患者在 90 天后 mRS≤2 （n = 64）：结论：Embotrap 3支架截留器在现实世界的患者群中具有较高的FPE率和最终再通率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Interventional Neuroradiology 医学-核医学

CiteScore

2.80

自引率

11.80%

发文量

192

审稿时长

6-12 weeks

期刊介绍： Interventional Neuroradiology (INR) is a peer-reviewed clinical practice journal documenting the current state of interventional neuroradiology worldwide. INR publishes original clinical observations, descriptions of new techniques or procedures, case reports, and articles on the ethical and social aspects of related health care. Original research published in INR is related to the practice of interventional neuroradiology...